Recently, keratin 18 (KRT18), a cytoskeletal protein that is upregulated in most types of tumors, has been associated with the clinical stage, cancer progression, deep tumor invasion, metastasis, and poor survival in NSCLC patients [56]. This evidence concerns the gene DNM2 and cancer.